During the past decade, Universitats-Herzzentrum Freiburg - Bad Krozingen conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 48 clinical trials were completed, i.e. on average, 55.2% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 32 clinical trials were completed. i.e. 128% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitats-Herzzentrum Freiburg - Bad Krozingen" #1 sponsor was "Abbott Medical Devices" with 14 trials, followed by "Deutsches Herzzentrum Muenchen" with 11 trials sponsored, "Biotronik AG" with 7 trials sponsored, "C. R. Bard" with 7 trials sponsored and "Cook Group Incorporated" with 7 trials sponsored. Other sponsors include 125 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitats-Herzzentrum Freiburg - Bad Krozingen" #1 collaborator was "Medtronic" with 5 trials as a collaborator, "Boston Scientific Corporation" with 4 trials as a collaborator, "Abbott Medical Devices" with 3 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 3 trials as a collaborator and "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include 102 different institutions and companies that were collaborators in the rest 106 trials.

According to Clinical.Site data, the most researched conditions in "Universitats-Herzzentrum Freiburg - Bad Krozingen" are "Coronary Artery Disease" (19 trials), "Peripheral Arterial Disease" (16 trials), "Heart Failure" (12 trials), "Peripheral Artery Disease" (12 trials) and "Peripheral Vascular Disease" (10 trials). Many other conditions were trialed in "Universitats-Herzzentrum Freiburg - Bad Krozingen" in a lesser frequency.

Most popular intervention types in "Universitats-Herzzentrum Freiburg - Bad Krozingen" are "Device" (119 trials), "Drug" (32 trials), "Procedure" (23 trials), "Other" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Empagliflozin" (3 trials), "Sham Procedure" (3 trials), "Ticagrelor" (3 trials) and "Best Medical Treatment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitats-Herzzentrum Freiburg - Bad Krozingen" are 174 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are 33 active trials in "Universitats-Herzzentrum Freiburg - Bad Krozingen". 1 are not yet recruiting, 11 are recruiting, 20 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 104 completed trials in Universitats-Herzzentrum Freiburg - Bad Krozingen, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Universitats-Herzzentrum Freiburg - Bad Krozingen, 5 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 84 trials that are defined as “Not Applicable".